Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy

Background: The use of rivaroxaban in clinical practice often deviates from manufacturer prescribing information. No studies have demonstrated an association between this practice and improved outcomes. Methods: We used the RIETE registry to assess the clinical characteristics of patients with pulmo...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Micco, Pierpaolo, Salazar, Vladimir Rosa, Capitan, Carmen Fernandez, Dentali, Francesco, Cuervo, Covadonga Gomez, Torres, Jose Luis Fernandez, Porras, Jose Antonio, Fidalgo, Angeles, Grandone, Elvira, Meseguer, Manuel Lopez, Monreal, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409848/
https://www.ncbi.nlm.nih.gov/pubmed/36013307
http://dx.doi.org/10.3390/life12081128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409848/
https://www.ncbi.nlm.nih.gov/pubmed/36013307
http://dx.doi.org/10.3390/life12081128

Ejemplares similares